FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2008398849> ?p ?o ?g. }

• W2008398849 endingPage "415" @default.
• W2008398849 startingPage "414" @default.
• W2008398849 abstract "We report a case of spontaneous hyphaema with no apparent predisposing cause except the assumption of an excessive warfarin dosage leading to over-anticoagulation; a literature search performed in Medline revealed only one case of spontaneous hyphaema resulting from warfarin therapy and no other ocular cause [1]. In case of overdosing, the incidence of warfarin-related hyphaemas could be higher, and it should be taken into account in clinical practice. A 72-year-old woman presented complaining of blurred vision and discomfort in her right eye of 1 day's duration. She had been taking 5 mg of warfarin sodium daily for atrial fibrillation for 2 years; she denied any other systemic disorder except hypertension and the history was negative for eye disease or treatment. The International Normalized Ratio (INR)/dosing was stable and the INR was regularly monitored every 3–4 weeks. The patient's compliance with the regimen was good; two episodes of self-limiting subconjunctival haemorrhage during the previous 12 months were reported. There was no recent illness and no new concurrent medications. Slit-lamp examination of the right eye revealed diffuse heame within the anterior chamber and a 2-mm layered hyphaema. No iris abnormalities were present. Gonioscopy was unremarkable and dilated fundus examination was within normal limits for age. The left eye was normal. Haematological evaluation disclosed prolonged activated partial thromboplastic time of 73.4 s (normal range 26–36 s) and INR of 5.56 (normal range 0.80–1.20). By the consent of the patient's haematologist, warfarin was discontinued until a subsequent haematological evaluation 3 days later. At that time she was asymptomatic and visual acuity was normal (best corrected visual acuity 1.0 decimels, or 20/20 snellen). The anterior chamber had cleared completely; minimum blood was visible on the iris surface and within the anterior iris stroma at 6 o'clock position. Gonioscopy and fundus examination were still negative for ocular abnormalities. Warfarin was reintroduced at a dose of 2.5 mg/day and the INR monitored 3 days later; the ocular bleeding has not recurred up to now. The use of the Naranjo probability scale revealed that the adverse event was possibly due to warfarin therapy (final score 4). Most spontaneous hyphaemas are associated with iris abnormalities, but this condition has been reported to occur from a variety of ocular causes (Table 1). Nunziata has reported a case of bilateral hyphaema in which no predisposing condition could be identified [2]. Various systemic conditions have been associated with spontaneous hyphaemas: haematological alterations such as sickle cell disease, acute lymphoblastic and myelocytic leukaemia, lymphomas, juvenile xanthogranuloma, histiocytosis X and many rheumatological disorders causing uveitis, such as Reiter's syndrome or ankylosing spondylitis (Table 1). Warfarin is the most commonly used drug for outpatient anticoagulation therapy and its main side-effect is bleeding; theoretically, this can occur in all organs, including the eye. Ocular bleeding can occur as subconjunctival, vitreal, retinal or choroidal haemorrhages; bloody tears have been also reported [3]. Cases of bleeding within the anterior chamber in non-operated eyes and linked to warfarin therapy in eyes with predisposing abnormalities have been previously reported by Greenfield and coworkers [4]. Aspirin and Ginkgo biloba also have been linked with spontaneous hyphaema [5, 6]. Ocular haemorrhages in warfarinized patients can be sight-threatening events, but often they are clinically benign and resolve without any sequelae. However, they may be the only indication that the patient is at risk for major bleeding episodes linked to over-anticoagulation. A number of studies have shown what amounts to an exponential increase in haemorrhagic complications as the INR increases to >5.0 [7]. Patients on warfarin therapy should be instructed to notice any change in their quality of vision; should any intraocular bleeding be diagnosed by the ophthalmologist, patients require immediate blood work and consultation with their primary care provider." @default.
• W2008398849 created "2016-06-24" @default.
• W2008398849 creator A5010920347 @default.
• W2008398849 creator A5040448818 @default.
• W2008398849 creator A5042772841 @default.
• W2008398849 creator A5052976475 @default.
• W2008398849 creator A5066029417 @default.
• W2008398849 date "2008-08-11" @default.
• W2008398849 modified "2023-10-17" @default.
• W2008398849 title "Spontaneous hyphaema in a patient on warfarin treatment" @default.
• W2008398849 cites W1984926874 @default.
• W2008398849 cites W2009717893 @default.
• W2008398849 cites W2012923240 @default.
• W2008398849 cites W2030186974 @default.
• W2008398849 doi "https://doi.org/10.1111/j.1365-2125.2008.03233.x" @default.
• W2008398849 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2526237" @default.
• W2008398849 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18637885" @default.
• W2008398849 hasPublicationYear "2008" @default.
• W2008398849 type Work @default.
• W2008398849 sameAs 2008398849 @default.
• W2008398849 citedByCount "12" @default.
• W2008398849 countsByYear W20083988492013 @default.
• W2008398849 countsByYear W20083988492014 @default.
• W2008398849 countsByYear W20083988492015 @default.
• W2008398849 countsByYear W20083988492017 @default.
• W2008398849 countsByYear W20083988492019 @default.
• W2008398849 countsByYear W20083988492021 @default.
• W2008398849 countsByYear W20083988492023 @default.
• W2008398849 crossrefType "journal-article" @default.
• W2008398849 hasAuthorship W2008398849A5010920347 @default.
• W2008398849 hasAuthorship W2008398849A5040448818 @default.
• W2008398849 hasAuthorship W2008398849A5042772841 @default.
• W2008398849 hasAuthorship W2008398849A5052976475 @default.
• W2008398849 hasAuthorship W2008398849A5066029417 @default.
• W2008398849 hasBestOaLocation W20083988492 @default.
• W2008398849 hasConcept C118487528 @default.
• W2008398849 hasConcept C126322002 @default.
• W2008398849 hasConcept C141071460 @default.
• W2008398849 hasConcept C2776301958 @default.
• W2008398849 hasConcept C2776391266 @default.
• W2008398849 hasConcept C2777288759 @default.
• W2008398849 hasConcept C2779161974 @default.
• W2008398849 hasConcept C2780892088 @default.
• W2008398849 hasConcept C2781092963 @default.
• W2008398849 hasConcept C2781413609 @default.
• W2008398849 hasConcept C2909255381 @default.
• W2008398849 hasConcept C42219234 @default.
• W2008398849 hasConcept C71924100 @default.
• W2008398849 hasConceptScore W2008398849C118487528 @default.
• W2008398849 hasConceptScore W2008398849C126322002 @default.
• W2008398849 hasConceptScore W2008398849C141071460 @default.
• W2008398849 hasConceptScore W2008398849C2776301958 @default.
• W2008398849 hasConceptScore W2008398849C2776391266 @default.
• W2008398849 hasConceptScore W2008398849C2777288759 @default.
• W2008398849 hasConceptScore W2008398849C2779161974 @default.
• W2008398849 hasConceptScore W2008398849C2780892088 @default.
• W2008398849 hasConceptScore W2008398849C2781092963 @default.
• W2008398849 hasConceptScore W2008398849C2781413609 @default.
• W2008398849 hasConceptScore W2008398849C2909255381 @default.
• W2008398849 hasConceptScore W2008398849C42219234 @default.
• W2008398849 hasConceptScore W2008398849C71924100 @default.
• W2008398849 hasIssue "3" @default.
• W2008398849 hasLocation W20083988491 @default.
• W2008398849 hasLocation W20083988492 @default.
• W2008398849 hasLocation W20083988493 @default.
• W2008398849 hasLocation W20083988494 @default.
• W2008398849 hasOpenAccess W2008398849 @default.
• W2008398849 hasPrimaryLocation W20083988491 @default.
• W2008398849 hasRelatedWork W1915834051 @default.
• W2008398849 hasRelatedWork W2000986683 @default.
• W2008398849 hasRelatedWork W2028525666 @default.
• W2008398849 hasRelatedWork W2053926762 @default.
• W2008398849 hasRelatedWork W2113569655 @default.
• W2008398849 hasRelatedWork W2972240255 @default.
• W2008398849 hasRelatedWork W3182488367 @default.
• W2008398849 hasRelatedWork W3206796326 @default.
• W2008398849 hasRelatedWork W3209317849 @default.
• W2008398849 hasRelatedWork W4220783631 @default.
• W2008398849 hasVolume "66" @default.
• W2008398849 isParatext "false" @default.
• W2008398849 isRetracted "false" @default.
• W2008398849 magId "2008398849" @default.
• W2008398849 workType "article" @default.